by Michael May | Aug 30, 2016
Michael May is President and CEO of CCRM, a leader in developing and commercializing regenerative medicine, cell and gene therapy technologies, Michael Rudnicki is Scientific Director and CEO of Stem Cell Network, with a mandate to translate stem cell research into...
by Holly Wobma | Aug 29, 2016
As humans, it is natural to categorize our environment. Usually, these groups include perceptible differences. -The red shirt vs. the blue shirt (not the near infrared vs. far infrared shirt) -The quiet (to our ears) sound vs. the loud sound -etc. Since we don’t...
by Stacey Johnson | Aug 25, 2016
Ten years ago today, Japanese scientists Shinya Yamanaka and Kazutoshi Takahashi published a paper announcing the creation of rodent induced pluripotent stem (iPS) cells, thus pioneering the field of iPS cell technology. They showed that they could convert adult cells...
by Jovana Drinjakovic | Aug 25, 2016
Science fiction became real life in September 2014, when a team of eye surgeons in Japan transplanted a body part, grown entirely in a dish, into the eye of a patient suffering from an eye disease. The retinal graft came from the patient’s skin cells, raising hopes...
by Holly Wobma | Aug 25, 2016
When you hear the word “stem cell,” I imagine this conjures up the image of cells that are special. Unlike most cells, stem cells can differentiate into other cell types. They hold the promise of curing many diseases, and thus they are continually the source of hype...
by David Kent | Aug 25, 2016
One of the most memorable moments of my young scientist career was a Keystone Conference in February 2006 in Whistler, BC where I first heard Professor Shinya Yamanaka describe the successful reprogramming of a skin cell into an induced pluripotent stem cell (iPSC)....
Comments